Hemoglobin levels correlate with serum soluble CD23 and TNF-Rs concentrations in patients with rheumatoid arthritis

Haematologia

Volumn 29, Issue 2, 1998, Pages 89-99

  Vaiopoulos, G ^a   Boki, K ^b   Kapsimali, V ^a   Coulocheri, S ^c   Papadaki, H A ^c   Eliopoulos, G D ^c,d  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b KAT HOSPITAL   (Greece)

^c UNIVERSITY OF CRETE   (Greece)

^d UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Anemia of chronic disease (ACD); Iron deficiency; Rheumatoid arthritis; Soluble CD23 molecules; Soluble TNF receptors

Indexed keywords

HEMOGLOBIN; IMMUNOGLOBULIN E RECEPTOR; LEUKOCYTE ANTIGEN; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ARTICLE; BLOOD; FEMALE; HUMAN; MALE; METABOLISM; RHEUMATOID ARTHRITIS;

ANTIGENS, CD; ARTHRITIS, RHEUMATOID; FEMALE; HEMOGLOBINS; HUMANS; MALE; RECEPTORS, IGE; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II;

EID: 0031614286     PISSN: 00176559     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Delespesse, G., Suter, U., Mossalayi, D., Bettler, B., Sarfati, M., Hofstetter, H., Kilcherr, E., Debre, P., Dalloul, A., Expression, structure and function of the CD23 antigen, Adv. Immunol. 49, 149 (1991).
2. Gordon, J., CD23 and B cell activation, Clin. Exp. Allergy 22, 199 (1992).
3. Sarfati, M., Bron, D., Lagneaux, L., Fonteyn, C., Prost, H., Delespesse, G., Elevation of IgE-binding factors in serum patients with B-cell-derived chronic lymphocytic leukemia, Blood 71, 94 (1988).
4. Bansal, A. S., Roberts, T., Hay, E. M., Kay, R., Pumphrey, R. S. H., Wilson, P. B., Soluble CD23 levels are elevated in the serum of patients with primary Sjögren's syndrome and systemic lupus erythematosus, Clin. Exp. Immunol. 89, 452 (1992).
5. Chomarat, P., Briolay, J., Banchereau, J., Miossec, P., Increased production of soluble CD23 in rheumatoid arthritis and its regulation by interleukin-4, Arthritis Rheum. 36, 234 (1993).
6. Matsumoto, T., Miike, T., Yamaguchi, K., Murakami, M., Kawabe, T., Yo-Doi, J., Serum levels of soluble IL-2 receptor, IL-4 and IgE-binding factors in childhood allergic diseases, Clin. Exp. Immunol. 85, 288 (1991).
7. Bansal, A. S., MacGregor, A. J., Pumphrey, R. S. H., Silman, A. J., Ollier, W. E. R., Wilson, P. B., Increased levels of sCD23 in rheumatoid arthritis are related to disease status, Clin. Exp. Rheumatol. 12, 281 (1994).
8. Tracey, K. J., Beutler, B., Lowry, S. F., Merryweather, J., Wolpe, S., Milsark, I. W., Hariki, R. J., Fahey, T. J., Zentella, A., Albert, J. D., Shock and tissue injury induced by recombinant human cachectin, Science 234, 470 (1986).
9. Havel, E. A., Evidence that tumor necrosis factor has an important role in antibacterial resistance, J. Immunol. 143, 2894 (1989).
10. Lantz, M., Gullberg, U., Nilsson, E., Olsson, I., Characterization in vitro of a human tumor necrosis factor-binding protein: a soluble form of a tumor necrosis factor receptor, J. Clin. Invest. 86, 1396 (1990).
11. Seckinger, P., Zhang, J. H., Hauptmann, B., Dayer, J. M., Characterization of a human tumor necrosis factor-α (TNF-α) inhibitor: evidence of immunological cross-reactivity with the TNF receptor, Proc. Natl. Acad. Sci. (USA) 87, 5188 (1990).
12. Spinas, G. A., Keller, U., Brockhaus, M., Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia, J. Clin. Invest. 90, 533 (1992).
13. Van Zee, K. J., Kohno, T., Fischer, E., Rock, G. S., Moldawer, L. L., Lowry, S. F., Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against expressive tumor necrosis factor-α in vitro and in vivo, Proc. Natl. Acad. Sci. (USA) 89, 4845 (1992).
14. Steiner, G., Studnicka-Benke, A., Witzmann, G., Hofler, E., Smolen, J., Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis, J. Rheumatol. 22, 406 (1995).
15. Barrera, P., Boerbooms, A. M. T. H., Janssen, E. M., Sauerwein, R. W., Gallati, H., Mulder, J., de Boo, T., Demacker, P. N., van de Putte, L. B., van der Meer, J. W., Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis α and interleukin-6 levels in rheumatoid arthritis, Arthritis Rheum. 36, 1070 (1993).
16. Kranz, S. B., Pathogenesis and treatment of the anemia of chronic disease, Am. J. Med. Sci. (USA) 307, 353 (1994).
17. Stockenhuber, F., Keil, M., Wurnig, C., Kurz, R. W., Gottsauner-Wolf, M., Balcke, P., Impaired erythropoietin responsiveness in anaemic rheumatoid arthritis patients: potential relation to immune mechanisms, Clin. Sci. 86, 633 (1994).
18. Katevas, P., Andonopoulos, A. P., Kourakli-Symeonidis, A., Manopoulou, E., Lafi, T., Makri, M., Zoumbos, N. C., Peripheral blood mononuclear cells from patients with rheumatoid arthritis suppress erythropoiesis in vitro via the production of tumor necrosis factor alpha, Eur. J. Haematol. 53, 26 (1994).
19. Vreugdenhil, G., Lowenberg, B., van Eijk, H. G., Swaak, A. J., Anaemia of chronic disease in rheumatoid arthritis. Raised serum interleukin-6 (IL-6) levels and effects of IL-6 and anti-IL-6 on in vitro erythropoiesis, Rheumatol. Int. 10, 127 (1990).
20. Arnett, F. C., Edworthy, S., Bloch, D. A., McShane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis Rheum. 31, 315 (1988).
21. Kumagai, S., Ishida, H., Iwai, K., Tsubata, T., Umehara, H., Ozaki, S., Suginoshita, T., Araya, S., Imura, H., Possible different mechanisms of B cell activation in systemic lupus erythematosus and rheumatoid arthritis: opposite expression of low-affinity receptors for IgE (CD23) on their peripheral B cells, Clin. Exp. Immunol. 78, 348 (1989).
22. Ross, C., Hansen, M. B., Chyberg, T., Breg, K., Autoantibodies to crude human leucocyte interferon (IFN), native human IFN, recombinant human IFN-alpha 2b and human IFN-gamma in healthy blood donors, Clin. Exp. Immunol. 82, 57 (1990).
23. Cope, A. P., Aderka, D., Doherty, M., Engelmann, H., Gibbons, D., Jones, A. C., Brennan, F. M., Maini, R. N., Wallach, D., Feldmann, M., Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluids of patients with rheumatic diseases, Arthritis Rheum. 35, 1160 (1992).
24. Roux-Lombard, P., Punzi, L., Hasler, F., Bas, S., Todesco, S., Gallati, H., Guerne, P. A., Dayer, J. M., Soluble tumor necrosis factor receptors in human inflammatory synovial fluids, Arthritis Rheum. 36, 485 (1993).
25. Deleuran, B. W., Chu, C.-Q., Field, M., Brennan, F. M., Mitchell, T., Feldmann, M., Maini, R. N., Localization of tumor necrosis factor receptors in synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis: implications for local actions of tumor necrosis factor α, Arthritis Rheum. 35, 1170 (1992).
26. Sakito, S., Ueki, Y., Eguchi, K., Kawabe, Y., Nagataki, S., Serum cytokines in patients with rheumatoid arthritis. Correlation of interferom gamma and tumor necrosis factor alpha with the characteristics of peripheral blood mononuclear cells, Rheumatol. Int. 15, 31 (1995).
27. Neidel, J., Schulze, M., Lindschau, J., Association between degree of boneerosion and synovial fluid-levels of tumor necrosis factor alpha in the knee-joints of patients with rheumatoid arthritis, Inflamm. Res. 44, 217 (1995).
28. Maini, R. N., Elliott, M. J., Brennan, F. M., Williams, R. O., Chu, C. Q., Paleolog, E., Charles, P. J., Taylor, P. C., Feldmann, M., Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease, Immunol. Rev. 144, 195 (1995).
29. Rankin, E. C., Choy, E. H., Kassimos, D., Kingsley, G. H., Sopwith, A. M., Isenberg, D. A., Panayi, G. S., The therapeutic effects of an engineered human anti-tumour necrosis factor alpha antibody (CDP571) in rheumatoid arthritis, Br. J. Rheumatol. 34, 334 (1995).